Safingol
Safingol (pronunciation: /ˈsæfɪŋɡɒl/) is a lipid-based drug that is currently under investigation for its potential use in the treatment of cancer. It is a synthetic derivative of sphingosine, a naturally occurring amino alcohol that plays a crucial role in cell signaling and apoptosis.
Etymology
The term "Safingol" is derived from the words "safe" and "sphingolipid". The prefix "safe" is used to indicate the drug's potential safety profile, while "sphingolipid" refers to the class of lipids from which Safingol is derived.
Pharmacology
Safingol acts by inhibiting protein kinase C, an enzyme that plays a key role in cell cycle regulation and signal transduction. By inhibiting this enzyme, Safingol can potentially halt the growth of cancer cells and induce apoptosis.
Clinical Trials
Safingol has been tested in several clinical trials for its potential use in treating various types of cancer, including breast cancer, lung cancer, and pancreatic cancer. The results of these trials have been promising, but further research is needed to fully understand the drug's efficacy and safety profile.
Related Terms
See Also
External links
- Medical encyclopedia article on Safingol
- Wikipedia's article - Safingol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski